First-In-Human Transcatheter Tricuspid Repair Feasible But Questions Remain (St. Paul's Hospital)
High-risk patients with severe tricuspid regurgitation who undergo repair of the tricuspid valve using a novel transcatheter system have a significant reduction in regurgitation severity, an improvement in functional status, and a reduction in peripheral edema, according to the results of a small first-in-human study.
Published December 8, 2015, in the Journal of the American College of Cardiology, the study results suggest the percutaneous approach might one day be a treatment option for patients unable to undergo tricuspid-valve repair surgery or those considered high risk for surgery who are refractory to medical therapy.
To TCTMD, study author Christopher Thompson, MD, of St. Paul’s Hospital (Vancouver, BC), said tricuspid regurgitation has not always been seen as a priority for physicians and surgeons.
Michael O'Riordan reports.
Angela White, St. Paul's Hospital Volunteer